Skip to main content
. 2021 May 4;337:108614. doi: 10.1016/j.mbs.2021.108614

Table 7.

Vaccine efficacy of some of the approved developments for emergency use.

Developer Vaccine name Vaccine efficacy %, (95% CI) Reference
Pfizer-BioNTech BNT162b2 95(90.3 –97.6 ) [46]
Gamaleya Institute Sputnik V 91.6(85.6 –95.2 ) [44]
Oxford University-AztraZeneca AZD1222 74.6(41.6 -88.9 ) [10]
Johnson & Johnsona Ad26.COV2.S 57 %, 66  % or 72  % [4]
Sinovac Biotecha CoronaVac 50.4 % [42]
a

No available information about the confidence intervals.